Xphyto Therapeutics acquires Vektor Pharma as company looks for rapid growth
Xphyto Therapeutics (CSE: XPHY) CEO Hugh Rogers sat down with Steve Darling from Proactive Vancouver with details about a key acquisition the company has made buying Vektor Pharma. They are a small German narcotics company.
Rogers telling Proactive why this deal will accelerate the company’s plans for medical cannabis in Germany. Rogers also shared details about the thin film delivery system they have also acquired.
Rogers telling Proactive why this deal will accelerate the company’s plans for medical cannabis in Germany. Rogers also shared details about the thin film delivery system they have also acquired.
People In This Video
No users are tagged in this video
